162 related articles for article (PubMed ID: 8160563)
1. Specific immunotherapy 3 years follow-up in asthmatic children.
Ferreira N; Trindade JC
Allergol Immunopathol (Madr); 1993; 21(5):185-92. PubMed ID: 8160563
[TBL] [Abstract][Full Text] [Related]
2. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
3. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
6. A case control study of dermatophagoides immunotherapy in children below 5 years of age.
Di Bernardino C; Di Bernardino F; Colombo R; Angrisano A
Allerg Immunol (Paris); 2002 Feb; 34(2):56-9. PubMed ID: 11933755
[TBL] [Abstract][Full Text] [Related]
7. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis.
Galli E; Chini L; Nardi S; Benincori N; Panei P; Fraioli G; Moschese V; Rossi P
Allergol Immunopathol (Madr); 1994; 22(1):18-22. PubMed ID: 8030579
[TBL] [Abstract][Full Text] [Related]
8. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy.
Akmanlar N; Altintaş DU; Güneşer KS; Yilmaz M; Bingöl G
Allergol Immunopathol (Madr); 2000; 28(4):213-8. PubMed ID: 11022267
[TBL] [Abstract][Full Text] [Related]
9. [Accelerated desensitization to Dermatophagoides pteronyssinus mites in children with asthma. Results of two years of immunotherapy].
Le Roux P; Le Luyer B
Allerg Immunol (Paris); 1991 Apr; 23(4):135-42. PubMed ID: 2069687
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-potentiated desensitization in children with asthma and mite allergy: a double-blind study.
Cantani A; Ragno V; Monteleone MA; Lucenti P; Businco L
J Investig Allergol Clin Immunol; 1996; 6(4):270-6. PubMed ID: 8844506
[TBL] [Abstract][Full Text] [Related]
11. Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides.
Marcucci F; Sensi LG; Caffarelli C; Cavagni G; Bernardini R; Tiri A; Riva G; Novembre E
Allergy; 2002 Jan; 57(1):23-8. PubMed ID: 11991284
[TBL] [Abstract][Full Text] [Related]
12. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients.
Mastrandrea F; Serio G; Minelli M; Minardi A; Scarcia G; Coradduzza G; Parmiani S
Allergol Immunopathol (Madr); 2000; 28(2):54-62. PubMed ID: 10804094
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of asthma desensitization in 1182 children, 592 asthmatic children and 590 nonatopic controls.
Cantani A; Micera M
Eur Rev Med Pharmacol Sci; 2005; 9(6):325-9. PubMed ID: 16479736
[TBL] [Abstract][Full Text] [Related]
14. [Topical nasal immunotherapy with Dermatophagoides pteronyssinus extract].
Muñoz-López F; Martín Mateos A; Moreira A; Martínez Marín F
Allergol Immunopathol (Madr); 1994; 22(3):132-4. PubMed ID: 7976962
[No Abstract] [Full Text] [Related]
15. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
Ibáñez Sendín MD
Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
[TBL] [Abstract][Full Text] [Related]
16. Importance of IgG4 determination in in vitro immunotherapy follow-up of inhalant allergens.
Oehling AK; Sanz ML; Resano A
J Investig Allergol Clin Immunol; 1998; 8(6):333-9. PubMed ID: 10028479
[TBL] [Abstract][Full Text] [Related]
17. [Round Table: Severe asthma in pediatrics: diagnosis and prognosis].
Garde Garde JM; Medina Pomares J
Allergol Immunopathol (Madr); 1999; 27(2):46-53. PubMed ID: 10354006
[TBL] [Abstract][Full Text] [Related]
18. [Blocking antibodies in Dermatophagoides allergy].
Sánchez Armengol A; Castillo Gómez J; Ortega Ruiz F; Segado Soriano A
Allergol Immunopathol (Madr); 1995; 23(6):271-6. PubMed ID: 8579005
[TBL] [Abstract][Full Text] [Related]
19. Comparative clinical-immunological study of oral and subcutaneous immunotherapy in children with extrinsic bronchial asthma.
Sánchez Palacios A; Schamann Medina F; Lamas Rua-Figueroa A; Bosch Millares C; Ramos Santos S; García Marrero JA
Allergol Immunopathol (Madr); 1989; 17(6):323-9. PubMed ID: 2635834
[TBL] [Abstract][Full Text] [Related]
20. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
